A new study shows that severe depression during and after pregnancy may be rooted in inflammation.
“Inflammation is an important and normal part of the immune system and, in early pregnancy, prevents the mother’s immune system from attacking the fetus,” said lead author Eric Achtyes, M.D., M.S., an associate professor at Michigan State University.
“However, when the inflammatory reaction is protracted or more intense than is optimal, it may lead to worsening depression in a subset of vulnerable women.”
Not to be mistaken for the rapidly passing “baby blues,” which is common right after delivery, pregnancy-related depression is a serious medical condition that can escalate in severity and may even require hospitalization.
One in five new mothers experience depression after pregnancy, with symptoms beginning during pregnancy and generally worsening after delivery. An estimated 14% have suicidal ideation during pregnancy.
“Pregnancy-related depression is common yet poorly understood,” said senior author Lena Brundin, M.D., Ph.D., an associate professor at the Van Andel Institute, an independent biomedical research and science education organization and senior author of the study.
“Biologically speaking, pregnancy is a major inflammatory event that can upend many of the body’s day-to-day molecular processes. If we can better understand these irregularities, it could lead to new ideas about how best to treat perinatal depression.”
For the study, the researchers analyzed blood samples from 165 patient volunteers at Pine Rest’s Mother and Baby Program and the Obstetrics and Gynecology Clinic at Spectrum Health in Grand Rapids.
The results show that several inflammatory factors appear to contribute to pregnancy-related depression onset and severity. Levels of IL-6 and IL-8 — both inflammatory chemicals called cytokines — were elevated.
In addition, levels of another cytokine called IL-2, which plays an important role in immune function, were low. At the same time, there was a drastic reduction in serotonin, an important chemical regulator of mood.
These changes point to alterations in the way that tryptophan, an amino acid required for serotonin production, is hijacked and pushed away by the kynurenine pathway, a molecular cascade closely linked to inflammation. The resulting loss of serotonin correlates with depressive symptom intensity; the less serotonin, the more severe the symptoms.
“Hopefully, this study will allow us to develop treatments that more specifically target those who are at risk for an ‘inflammatory’ perinatal depression,” said Achtyes.
The study findings are published in the journal Brain, Behavior and Immunity.
Source: Van Andel Research Institute